Massachusetts · 194th Legislature (2025-2026) · Bill
H 2217: An Act relative to opioid reversal drugs
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
H 2217 is a bill introduced in the Massachusetts House on February 27, 2025. According to its official title, it concerns: An Act relative to opioid reversal drugs. Primary sponsor: Sally Kerans (Democratic). Most recent recorded action (March 30, 2026): Accompanied a study order, see H5319 (under House Rule 27).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Representative Kerans of Danvers, a petition (accompanied by bill, House, No. 2217) of Sally P. Kerans relative to opioid reversal drugs. Mental Health, Substance Use and Recovery.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Sally Kerans | Primary sponsor | Democratic | House | 13th Essex |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Accompanied a study order, see H5319 (under House Rule 27)
- Hearing scheduled for 11/03/2025 from 01:00 PM-05:00 PM in A-2
- Senate concurred
- Referred to the committee on Mental Health, Substance Use and Recovery